Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Ali, Abdul Hai"'
Publikováno v:
Leukemia & Lymphoma. 56:3387-3392
Interleukin-7 (IL-7) is a critical cytokine in early B and T cell development. Peripheral T cell expansion and thymopoiesis and is a result of the ongoing reconstitution from uncommitted stem cells after transplant. We investigated the efficacy of ex
Autor:
Iris Barshack, Yosef Yarden, S. Sinha, N. Shirazi, Yonatan Cohen, Mattia Lauriola, Moshit Lindzen, Silvia Carvalho, Ali Abdul-Hai, Keren Levanon, Jacob Korach, Amir Onn, Gordon B. Mills
Publikováno v:
Oncogene. 35:438-447
Growth factors of the epidermal growth factor (EGF)/neuregulin family are involved in tumor progression and, accordingly, antibodies that intercept a cognate receptor, epidermal growth factor receptor (EGFR)/ERBB1, or a co-receptor, HER2, have been a
Autor:
Simcha Samuel, Michael Y. Shapira, Ali Abdul-Hai, Igor B. Resnick, Reuven Or, Panagiotis Tsirigotis, Badran Abu Zaid, Itamar Grotto, Lillian Dray
Publikováno v:
Leukemia & Lymphoma. 54:2480-2484
We compared the tolerability and anti-myeloma effect of two conditioning regimens for autologous stem cell transplant (auto-SCT) in consecutive groups of patients. Protocol 1 was the earlier, and consisted of the combination of three agents in a sequ
Autor:
Igor B. Resnick, Aliza Ackerstein, Menachem Bitan, Benjamin Gesundheit, Panagiotis Tsirigotis, Reuven Or, M Y Shapira, Shimon Slavin, Simcha Samuel, Ali Abdul-Hai
Publikováno v:
Bone Marrow Transplantation. 45:1189-1196
The influence of graft composition on the outcome of reduced-intensity (RIC) allogeneic PBSC transplantation (allo-PBSC) remains controversial. In this study, we analyzed the impact of CD34+ cell dose on the incidence of GVHD, and on the outcome afte
Autor:
Simcha Samuel, Panagiotis Tsirigotis, Aliza Ackerstein, Shimon Slavin, Memet Aker, Michael Y. Shapira, Reuven Or, Menachem Bitan, Igor B. Resnick, Ali Abdul-Hai
Publikováno v:
Biology of Blood and Marrow Transplantation. 14:409-417
The effect of ABO-incompatibility on transplantation outcome remains a controversial issue, with many of the reported studies showing conflicting results. In this study, we evaluate: the association between ABO-incompatibility and myeloid engraftment
Autor:
Shimon Slavin, Michael Y. Shapira, Igor B. Resnick, Panagiotis Tsirigotis, Reuven Or, Ali Abdul-Hai
Publikováno v:
Critical Reviews in Oncology/Hematology. 64:49-63
The development of reduced intensity or non-myeloablative conditioning (NST) in preparation for allogeneic stem cell transplantation (SCT) revolutionized the field and led to reconsideration of the dogma of upper age limit that was set up by the tran
Autor:
Avraham Amar, Menachem Bitan, Aliza Ackerstein, M Y Shapira, Igor B. Resnick, Simcha Samuel, Benjamin Gesundheit, S. Slavin, Panagiotis Tsirigotis, Reuven Or, Ali Abdul-Hai, Memet Aker
Publikováno v:
Bone Marrow Transplantation. 40:957-964
The only radical cure for thalassemia major patients today is the replacement of the defective hematopoietic system by allogeneic stem cell transplantation (allo-SCT). The major obstacles for the application of allo-SCT even from matched family membe
Autor:
Ali Abdullah, Alon Basevitz, Ali Abdul-Hai, Yuval Binder, Stephen Malnick, Pavel Alin, Avital Brand, Yazid Gharaba, Ehud Melzer, Nadia Ziv-Sokolowski, Ofer Raz, Marina Somin
Publikováno v:
Lancet (London, England). 385(9978)
Autor:
Ronen Alon, Hava Gil-Henn, Rotem Ben-Hamo, Marcelo Ehrlich, Nir Ben-Chetrit, Yosef Yarden, Tomer Itkin, Wolfgang J. Koestler, Dalia Seger, Silvia Carvalho, Carlos Caldas, Maicol Mancini, Ali Abdul-Hai, Daniela Aleida Ferraro, David Chetrit, Fresia Pareja, Mattia Lauriola, Marc Symons, Kirti Shukla, Ziv Shulman, Tsvee Lapidot, Hadas Cohen-Dvashi, Cindy Körner, Fernanda Milanezi, Moshit Lindzen, Merav Kedmi, Fernando Schmitt, Stefan Wiemann, Haim Barr, Sol Efroni, Roslin Russell
Publikováno v:
Science signaling. 8(360)
Amplified HER2, which encodes a member of the epidermal growth factor receptor (EGFR) family, is a target of effective therapies against breast cancer. In search for similarly targetable genomic aberrations, we identified copy number gains in SYNJ2,
Autor:
Moshit Lindzen, Christel Larbouret, Myriam Chentouf, Manjusha Ghosh, Lucile Mounier, Yosef Yarden, Sai Dunoyer, Sara Lavi, Ali Abdul-Hai, Thierry Chardès, André Pèlegrin, Michael Sela, Hervé Bazin, Nadège Gaborit, Orith Leitner, Maicol Mancini
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2015, 112 (3), pp.839-844. ⟨10.1073/pnas.1423645112⟩
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2015, 112 (3), pp.839-844. ⟨10.1073/pnas.1423645112⟩
International audience; The human EGF receptor (HER/EGFR) family of receptor tyrosine kinases serves as a key target for cancer therapy. Specifically, EGFR and HER2 have been repeatedly targeted because of their genetic aberrations in tumors. The the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a47177d06f7bcf4618011c9c8e5e170
https://hal.umontpellier.fr/hal-02276327/document
https://hal.umontpellier.fr/hal-02276327/document